| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 300,000 | 01 Apr 2025 | Direct | ||
| Acumen Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25,000 | 15 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 01 Apr 2025 | 1 | $0 | 4 | Chief Medical Officer | 03 Apr 2025, 17:00 |
| RAPP | Rapport Therapeutics, Inc. | 03 Mar 2025 | 0 | $0 | 3 | Chief Medical Officer | 05 Mar 2025, 17:00 |
| ABOS | Acumen Pharmaceuticals, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:24 |
| ABOS | Acumen Pharmaceuticals, Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 16:19 |
| ABOS | Acumen Pharmaceuticals, Inc. | 30 Jun 2021 | 0 | $0 | 3 | Director | 30 Jun 2021, 18:58 |